Mucormycosis/Black Fungus Disease in COVID Patients: Introduction, Causative agent, Sign and symptoms, Lab Diagnosis, Treatment, Prevention and Control

Mucormycosis/Black Fungus Disease in COVID Patients: Introduction, Causative agent, Sign and symptoms, Lab Diagnosis, Treatment, Prevention and Control

Introduction of Mucormycosis/Black Fungus Disease

Mucormycosis/black fungus disease (previous zygomycosis) is a fungal infection that principally affects people who are immunocompromised or on medication for other health problems that reduce their ability to fight environmental pathogens. It may be suspected in  COVID-19 patients, diabetics, or immunosuppressed individuals having the following conditions-

  • Sinusitis – nasal blockage or congestion, nasal discharge (blackish/bloody), local pain on the cheekbone
  • One-sided facial pain, numbness, or swelling
  • Blackish discoloration over the bridge of nose/palate
  • Toothache, loosening of teeth, jaw involvement
  • Blurred or double vision with pain; fever, skin lesion; thrombosis and  necrosis (eschar)
  • Chest pain, pleural effusion, hemoptysis, worsening of respiratory symptoms

Mode of transmission of Mucormycosis/Black Fungus Disease

Mucormycosis/black fungus disease mode of transmission is via spores. Sinuses or lungs of such individuals get affected after fungal spores are inhaled from the air or the skin after the fungus enters the skin through a cut, burn, or another type of skin injury.

Predisposing Factors of Mucormycosis/Black Fungus Disease

Mucormycosis/black fungus disease is common in people who have the following conditions-

  • Uncontrolled diabetes mellitus
  • Immunosuppression by steroids
  •  Prolonged ICU stay
  • Co-morbidities – post-transplant/malignancy
  •  Voriconazole therapy
  • the low number of white blood cells (especially neutropenia)
  • iron overload or hemochromatosis
  • Skin injury due to surgery, burns, or wounds
  • Prematurity and low birthweight (for neonatal gastrointestinal mucormycosis)

Causative agents of Mucormycosis/Black Fungus Disease

The causative agents of mucormycosis/ black fungus diseases are as follows-

  • Rhizopus,
  • Mucor,
  • Cunninghamella,
  • Apophysomyces,
  • Lichtheimia (formerly Absidia),
  • Saksenaea,
  • Rhizomucor, and
  • other species.

Pathogenicity

Mucormycosis is a serious but rare fungal infection caused by three genera of class micromycetes, Mucor, Rhizopus, and Absidia. These fungi are saprophytes of soil, manure, and decaying vegetables. Mucormycosis mainly affects people who with weakened immune systems. It most commonly affects the sinuses or the lungs after inhaling fungal spores from the air, or the skin after the fungus enters the skin through a cut, burn, or another type of skin injury. Absidia may also cause keratitis. However, it can occur in nearly any part of the body even bone to brain. Gastrointestinal mucormycosis may occur in malnutrition, uremia, and diarrhoeal diseases.

Sign and symptoms of Mucormycosis/Black Fungus Disease

  • Pain and redness around eyes and/or nose
  • Fever
  • Headache
  • Coughing
  • Shortness of breath
  • Bloody vomits
  • Altered mental status
  • bloody or blackish mucus emission from the nose
  • Distinct blackish discoloration on the bridge of the nose
  • Pain on only one side of the face, cheekbones, numbness
  • Blurred vision
  • Pleural effusion

Laboratory Diagnosis of Mucormycosis/Black Fungus Disease

Specimens: Specimens depend on the nature of infection sites. They may be scrapping from the lesions, pus, sputum, nasal discharge, etc.

Direct Microscopy- KOH mount: Presence of fungal elements ( non-septate hyphae)

Histopathological examination: Histological sections stained  H & E stain reveal the presence of hyphae.

Culture: Colonies are very fast-growing, cottony to fluffy, white to yellow, becoming dark grey, with the development of sporangia.

Identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) technique

Molecular techniques targeting different loci i.e. ribosomal targets 18S, 28S and Internal transcribed spacer (ITS); FTR1 gene, cytochrome b

Treatment of Mucormycosis/Black Fungus Disease

Treatment completes  in either using antifungal drugs or surgery or both

Useful antifungal drugs are-

  • Amphotericin B
  • Posaconazole

Surgery

Removal affected tissue

Prevention and Control  of Mucormycosis/Black Fungus Disease

  • Use masks (N95 respirators) if you are visiting dusty construction sites.
  • Wear shoes, long trousers, long sleeve shirts, and gloves while doing outdoor activities such as gardening, yard work, or visiting wooded areas.
  • To decrease the chances of developing a skin infection, clean skin injuries well with soap and water, particularly if they have been exposed to soil or dust.
  • Control glucose level in hyperglycaemic patient
  • Monitor blood glucose level post-COVID-19 discharge and also in diabetics
  • Use steroid properly – correct timing, correct dose, and duration
  • Use clean, sterile water for humidifiers during oxygen therapy

Further Reading

  1. https://www.cdc.gov/fungal/diseases/mucormycosis/index.html
  2. https://www.sciencedirect.com/science/article/pii/S1198743X15010320
  3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463105/
  4. https://www.icmr.gov.in/pdf/covid/techdoc/Mucormycosis_ADVISORY_FROM_ICMR_In_COVID19_time.pdf
  5. https://emedicine.medscape.com/article/222551-overview#:~:text=Rhizopus%20species%20are%20the%20most,%2C%20Rhizomucor%2C%20and%20other%20species.
  6. https://www.netmeds.com/health-library/post/mucormycosis-black-fungus-why-are-covid-19-patients-at-risk-here-are-icmr-guidelines-for-prevention
  7. https://www.bbc.com/news/world-asia-india-57027829
  8. https://theconversation.com/what-is-mucormycosis-the-fungal-infection-affecting-covid-patients-in-india-160707
[2575 visitors]

Comments

© 2026 Universe84a.com | All Rights Reserved

16013801

Visitors